Potassium Replacement Calculator
Calculate potassium replacement dosing from deficit and target serum potassium level. Enter values for instant results with step-by-step formulas.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
Potassium Replacement Calculator
Calculator
Adjust values & calculateEnter your values below. Every result is computed in your browser โ no data is sent to any server.
Formula: Estimated Deficit (mEq) = based on severity tiers: mild (100 mEq per 1 mEq/L below 4.0), moderate (200 mEq per 1 mEq/L below 3.5), severe (4โฆ
Worked example โ IV Dose: 20 mEq | Oral Dose: 40 mEq | Recheck in 2-4 hours | Estimated Deficit: ~300 mEq
Formula
Estimated Deficit (mEq) = based on severity tiers: mild (100 mEq per 1 mEq/L below 4.0), moderate (200 mEq per 1 mEq/L below 3.5), severe (400+ mEq per 1 mEq/L below 3.0)
Potassium deficit estimation is inherently approximate because 98% of total body potassium is intracellular. A 0.3 mEq/L decrease in serum K below 3.5 corresponds to roughly 100 mEq total body deficit. The relationship is nonlinear with progressively larger deficits at lower serum levels. Actual replacement needs vary based on ongoing losses, acid-base status, and renal function.
Worked Examples
Example 1: Moderate Hypokalemia in Post-Surgical Patient
Problem:A 70 kg patient 2 days post-abdominal surgery has a serum K of 3.0 mEq/L with target of 4.0 mEq/L. Normal renal function. Patient is tolerating oral intake.
Solution:Current K: 3.0 mEq/L, Target: 4.0 mEq/L Severity: Moderate hypokalemia Estimated deficit: ~200-400 mEq Recommended: IV 20 mEq KCl at 10 mEq/hr + Oral 40 mEq KCl Recheck level in 2-4 hours after IV dose Expected rise: ~0.3 mEq/L per 40 mEq replaced
Result:IV Dose: 20 mEq | Oral Dose: 40 mEq | Recheck in 2-4 hours | Estimated Deficit: ~300 mEq
Example 2: Severe Hypokalemia with EKG Changes
Problem:A 65 kg patient presents with K of 2.2 mEq/L, EKG showing U waves and prolonged QT. Target K 4.0 mEq/L. Normal renal function.
Solution:Current K: 2.2 mEq/L, Target: 4.0 mEq/L Severity: SEVERE hypokalemia - medical emergency Estimated deficit: ~500-800 mEq Recommended: IV 40 mEq KCl via central line at 20 mEq/hr Continuous cardiac telemetry MANDATORY Check magnesium level and replace if low Recheck K every 1-2 hours during active replacement
Result:IV Dose: 40 mEq via central line | Rate: 20 mEq/hr | Continuous monitoring | Check Mg level
Frequently Asked Questions
What is hypokalemia and when does it require treatment?
Hypokalemia is defined as a serum potassium level below 3.5 mEq/L and is one of the most common electrolyte disorders encountered in clinical practice, occurring in up to 20 percent of hospitalized patients. Treatment urgency depends on the severity and clinical context. Mild hypokalemia of 3.0 to 3.5 mEq/L is often asymptomatic and can be treated with oral supplementation. Moderate hypokalemia of 2.5 to 3.0 mEq/L may cause muscle weakness, cramps, and fatigue, and usually requires a combination of oral and IV replacement. Severe hypokalemia below 2.5 mEq/L is a medical emergency that can cause life-threatening cardiac arrhythmias, respiratory failure from diaphragm weakness, and rhabdomyolysis, requiring urgent IV replacement with continuous cardiac monitoring.
How is potassium deficit estimated from serum levels?
Estimating total body potassium deficit from serum levels is inherently imprecise because only about 2 percent of total body potassium is extracellular and measurable in serum, while 98 percent resides intracellularly. As a general approximation, each 0.3 mEq/L decrease in serum potassium below 3.5 mEq/L corresponds to approximately a 100 mEq total body deficit. However, this relationship is not linear; as potassium drops further, the deficit per unit decrease grows larger because intracellular stores become progressively depleted. A patient with a serum K of 3.0 mEq/L may have a deficit of 200 to 400 mEq, while a patient with K of 2.0 mEq/L may have a deficit of 400 to 800 mEq. Factors like acid-base status also affect the relationship between serum and total body potassium, with alkalosis shifting potassium intracellularly and making serum levels appear lower.
What is the maximum safe IV potassium infusion rate?
The maximum safe IV potassium infusion rate depends on the access site and clinical urgency. For peripheral IV access, the generally accepted maximum rate is 10 mEq per hour at a concentration no greater than 40 mEq per liter, as higher concentrations cause painful phlebitis and vein irritation. For central venous access, rates up to 20 mEq per hour can be administered at concentrations up to 80 mEq per liter, though some critical care protocols allow up to 40 mEq per hour in life-threatening situations with continuous cardiac monitoring and frequent serum level checks every one to two hours. Regardless of the route, continuous telemetry monitoring is mandatory when infusing potassium at rates greater than 10 mEq per hour. An important safety principle is that potassium should never be given as an IV push or rapid bolus because this can cause fatal cardiac arrest.
When should oral versus IV potassium replacement be used?
Oral potassium replacement is preferred whenever possible because it is safer, more physiological, less painful, and less likely to cause dangerous hyperkalemia from overshoot. Oral replacement is appropriate for mild hypokalemia of 3.0 to 3.5 mEq/L in patients who can tolerate oral intake, chronic potassium supplementation, and outpatient management. Common oral formulations include potassium chloride tablets (8 to 20 mEq each), liquid solutions, and effervescent preparations. IV replacement is necessary when serum potassium is below 2.5 mEq/L, when the patient is symptomatic with arrhythmias or severe weakness, when the patient is NPO or has severe nausea and vomiting preventing oral intake, or when rapid correction is needed such as in digitalis toxicity. Many moderate cases benefit from a combination approach using IV replacement for initial rapid correction followed by oral supplementation for ongoing maintenance.
What monitoring is required during potassium replacement?
Monitoring during potassium replacement therapy depends on the severity of hypokalemia and the rate of replacement. For severe hypokalemia or IV replacement rates exceeding 10 mEq per hour, continuous cardiac telemetry monitoring is essential to detect arrhythmias including peaked T waves, prolonged QT interval, ST depression, and U waves that may indicate dangerous potassium levels. Serum potassium levels should be rechecked every 2 to 4 hours during active IV replacement and every 4 to 6 hours during oral replacement. Renal function (BUN, creatinine, urine output) must be monitored because impaired kidney function significantly increases the risk of hyperkalemia from replacement therapy. Magnesium levels should be checked concurrently because hypomagnesemia makes hypokalemia refractory to treatment. Patients should be monitored for symptoms of hypokalemia resolution (improved weakness, resolution of EKG changes) and hyperkalemia development (bradycardia, peaked T waves).
Why does hypomagnesemia need to be corrected before potassium replacement?
Hypomagnesemia is present in approximately 40 to 60 percent of patients with hypokalemia, and correcting magnesium deficiency is essential for successful potassium repletion. Magnesium is required for the proper function of the Na-K-ATPase pump, which maintains the intracellular potassium gradient and is the primary mechanism for potassium reabsorption in the renal tubules. When magnesium is deficient, the Na-K-ATPase pump functions poorly, leading to increased renal potassium wasting that persists regardless of how much potassium is administered. This creates a situation where potassium replacement appears ineffective, with levels remaining low despite aggressive supplementation. The recommended approach is to check and correct magnesium levels simultaneously with potassium replacement. Typically, 1 to 2 grams of IV magnesium sulfate or oral magnesium oxide should be administered alongside potassium repletion in patients with documented or suspected hypomagnesemia.
How does acid-base status affect potassium levels?
Acid-base disturbances have a significant and clinically important effect on serum potassium levels through transcellular shifts. In metabolic acidosis, hydrogen ions move into cells in exchange for potassium ions moving out, raising the serum potassium level by approximately 0.6 mEq/L for each 0.1 unit decrease in pH. This means a patient in diabetic ketoacidosis with a pH of 7.1 and a serum K of 5.0 may actually have severe total body potassium depletion that will become apparent as the acidosis is corrected. Conversely, metabolic alkalosis causes potassium to shift intracellularly, lowering serum levels by approximately 0.3 to 0.5 mEq/L for each 0.1 unit increase in pH. This is why vomiting-induced metabolic alkalosis commonly causes hypokalemia. Understanding these relationships is critical for planning potassium replacement because the true deficit may be much larger or smaller than what the serum level initially suggests.
What EKG changes are seen with hypokalemia?
Hypokalemia produces characteristic electrocardiographic changes that progress in severity with worsening potassium depletion. The earliest finding is flattening of the T wave, which may be subtle and easily missed. As potassium drops further, U waves appear, which are small positive deflections following the T wave and are most prominent in leads V2 and V3. Progressive hypokalemia causes ST segment depression, T wave inversion, and prolongation of the QT interval, which increases the risk of torsades de pointes, a potentially fatal ventricular arrhythmia. Severe hypokalemia can widen the QRS complex and cause dangerous arrhythmias including ventricular tachycardia and ventricular fibrillation. In patients taking digoxin, even mild hypokalemia significantly increases the risk of digitalis toxicity and associated arrhythmias because potassium and digoxin compete for binding sites on the Na-K-ATPase pump.
What are common causes of hypokalemia in hospitalized patients?
Hypokalemia in hospitalized patients most commonly results from gastrointestinal and renal losses, medications, and transcellular shifts. Gastrointestinal causes include vomiting, nasogastric suction, diarrhea, and intestinal fistulas. The most frequent medication-related cause is diuretic therapy, particularly loop diuretics like furosemide and thiazide diuretics like hydrochlorothiazide, which increase renal potassium excretion. Other medications causing hypokalemia include amphotericin B, aminoglycosides, corticosteroids, and insulin. Transcellular shift causes include insulin administration driving potassium intracellularly, beta-2 agonist therapy (albuterol), correction of metabolic acidosis, and refeeding syndrome in malnourished patients. Inadequate dietary intake alone rarely causes significant hypokalemia but can contribute in combination with other factors. Identifying and addressing the underlying cause is essential to prevent recurrent hypokalemia after replacement.
How do you adjust potassium replacement for renal insufficiency?
Potassium replacement in patients with renal insufficiency requires careful dose reduction and closer monitoring because impaired kidneys cannot excrete excess potassium efficiently, dramatically increasing the risk of life-threatening hyperkalemia. For patients with mild to moderate renal impairment (GFR 30 to 60 mL/min), replacement doses should be reduced by approximately 50 percent and serum levels checked more frequently, every 2 to 4 hours during active replacement. For patients with severe renal impairment (GFR below 30 mL/min) or those on dialysis, potassium replacement should generally be avoided unless the hypokalemia is severe and symptomatic, and then only with continuous cardiac monitoring and frequent serum checks every 1 to 2 hours. IV replacement rates should not exceed 10 mEq per hour regardless of access type. Concurrent medications that affect potassium handling (ACE inhibitors, ARBs, potassium-sparing diuretics, trimethoprim) should be reviewed and potentially held during active replacement.
References
Background & Theory
History
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist ยท Editorial policy
Related Calculators
๐งฎMagnesium Replacement Calculator
Calculate magnesium replacement dose from serum level and weight for hypomagnesemia.
๐งฎSodium Deficit Calculator
Calculate sodium replacement needs for hyponatremia from current and target sodium levels.
๐งฎIron Deficit Calculator: Ganzoni Replacement Dose
Calculate iron deficit and replacement dose from hemoglobin, weight, and target levels.
๐งฎBicarbonate Deficit Calculator
Calculate sodium bicarbonate replacement needs for metabolic acidosis correction.
๐งฎChads2 Score Calculator
Calculate the CHADS2 stroke risk score for patients with non-valvular atrial fibrillation.
๐งฎCha2ds2-Vasc Score Calculator
Calculate CHA2DS2-VASc score for stroke risk stratification in atrial fibrillation patients.
๐งฎHas-Bled Score Calculator
Assess bleeding risk in patients on anticoagulation using the HAS-BLED scoring system.
๐งฎHEART Score Calculator for Chest Pain Risk
Risk-stratify emergency department patients with chest pain using the HEART score.